The Fetal Medicine Foundation 17th World Congress in Fetal Medicine, Athens, Greece
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • High NT
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidney
    • Skeleton
    • Tumors
    • Syndromes
    • Other
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infections
  • Labor / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

Impaired placentation

  1. A case of abnormal placentation and severe late-onset preeclampsia View pdf
  2. A case of conservative surgery as treatment option for placenta percreta View pdf
  3. A case of placenta accreta left in situ View pdf
  4. A case of placental mesenchymal dysplasia View pdf
  5. A case report of a prenatal ultrasound diagnosis of a urachal cyst View pdf
  6. A comparison between outcomes of isolated short femur length vs intrauterine growth restriction pregnancies View pdf
  7. A novel sign of color Doppler for severe placenta accreta spectrum View pdf
  8. A placental histopathological changes in the growth-restricted fetus and consequent neonatal outcomes View pdf
  9. Adverse pregnancy outcomes and complications associated with low pregnancy-associated plasma protein A View pdf
  10. Application of aCGH in stillbirth investigation View pdf
  11. Applying the FMF 2012 algorithm for PE screening to Brazilian population: The effect of ethinicty on screening for PE View pdf
  12. Assessment of third trimester serum cystatin C levels in women with preeclampsia: a case-control study View pdf
  13. Association of feto-placental Doppler with placental histopathology in fetal growth restriction and preeclampsia View pdf
  14. Bubbles and Lines: visual mnemonics to aid in the diagnosis of vasa previa View pdf
  15. Calculation of cerebellar volume using an automatic segmentation model and cerebellar volume in IUGR fetuses View pdf
  16. Chronic villitis/intervillositis of unknown etiology: Clinical features and perinatal outcome View pdf
  17. Comparison of inter-assay measured levels of soluble fms-like tyrosine kinase-1 and placental growth factor View pdf
  18. Comparison of perinatal outcomes of spontaneous versus assisted conceived twin pregnancies with time trend View pdf
  19. Comparison of screening performance of first-trimester prediction algorithms for preeclampsia View pdf
  20. Determination of multiples of median for biophysical and biochemical markers of preeclampsia View pdf
  21. Diagnosis of pregnancy complications with the sFlt-1/PlGF ratio View pdf
  22. Diagnostic efficiency of the sFLT-1/PLGF ratio in screening for preeclampsia in women with chronic hypertension View pdf
  23. Do angiogenic factors improve detection of late-onset FGR? View pdf
  24. Doctor as patient: Severe Preclampsia View pdf
  25. Effect of aspirin on preeclampsia and uterine artery Doppler View pdf
  26. Effect of aspirin on small for gestational age neonates and uterine artery Doppler View pdf
  27. Effect of endothelial therapy on asymptomatic angiogenic imbalance in pregnancy View pdf
  28. Effects of endovascular embolization of uterine arteries before delivery in placenta previa and placenta accreta View pdf
  29. Elastography and placenta: a systematic review View pdf
  30. Evaluation of serum cathepsin B, D and L levels in women with late-onset preeclampsia View pdf
  31. Evaluation of the quality and reliability of middle cerebral artery and umbilical artery Doppler images View pdf
  32. Evaluation of the relation between vascular cell adhesion molecule-1 and morbidly adherent placenta View pdf
  33. Expression of placental growth factor in pregnancy and its predictive value for preeclampsia View pdf
  34. External validation of the fetal medicine foundation algorithm for prediction of preecampsia in a chilean population View pdf
  35. Feasibility of the transverse method to access the uterine artery PI measurement for screening of pre-eclampsia View pdf
  36. Fetal and placental tissue and the role of 3D and Doppler ultrasound in lung maturity in PE and GDM View pdf
  37. Fetal cardiovascular characterization in a rabbit model of intrauterine growth restriction View pdf
  38. Fetal growth restriction classification: a mixture model approach View pdf
  39. Fetal growth restriction prognosis: a competing risks model View pdf
  40. Fetoscopic findings of poor prognosis in selective fetal growth restriction type II View pdf
  41. First trimester growth velocity and type of conception in the prediction of small for gestational age View pdf
  42. First-trimester prediction of preeclampsia: external validation of the FMF algorithm View pdf
  43. FMF prediction of preeclampsia and small for gestational age in women with antiphospholipid syndrome View pdf
  44. Furcate cord insertion of the umbilical cord: pathological and clinical characteristics in 132 cases View pdf
  45. Growth patterns of severe preeclampsia cases: a retrospective cohort study View pdf
  46. Haitian term newborns present lower birth weight than chilean term newborns View pdf
  47. How much of a predictor is low PAPP-A for poor perinatal outcome? View pdf
  48. Impact of targeted scanning protocols on perinatal outcomes on risk of placenta accreta spectrum or vasa previa View pdf
  49. Implementation of the sFlt-1/PlGF ratio in suspected preeclampsia View pdf
  50. Incidence of vasa previa and velamentous cord insertion in IVF/ICSI pregnancy: a meta-analysis View pdf
  51. Left ventricular hypertrophy in preeclampsia/gestational hypertension View pdf
  52. Listen to your eyes during preeclampsia View pdf
  53. Local and personalized operator-tailored fetal weight estimation formulas are better than standard formulas View pdf
  54. Low PAPP-A and small for gestational age: Is reduction in PAPP-A cut-off for scan referral safe and cost-effective? View pdf
  55. Maternal abnormal diastolic relaxation in pregnancies with gestational hypertension/preeclampsia View pdf
  56. Maternal age as a risk factor in pregnancy and perinatal period View pdf
  57. Measurement of biomarkers for first-trimester preeclampsia screening in Asia View pdf
  58. Metabolic profiling and targeted lipidomics in small for gestational age and fetal growth restriction View pdf
  59. MRI: Late FGR and reduction in neonatal brain size, maturation and connectivity View pdf
  60. Neurobehavioral outcomes in a well-characterized cohort of pregnancies complicated by FGR and/or PE View pdf
  61. Patterns of placental stromal-vascular lesions in preeclampsia and fetal growth restriction View pdf
  62. Placenta praevia and low-lying placenta: is placental edge thickness a reliable predictor of perinatal outcomes? View pdf
  63. Placental ageing in term small for gestational age and growth restricted fetuses View pdf
  64. Placental elastography: a new approach based on Shear Wave Speed dispersion View pdf
  65. PlGF, sFlt-1 and sFlt-1/PlGF ratio during pregnancy in women without and with PE View pdf
  66. Predicting aspirin resistance by biomarkers at 11-13 weeks' gestation View pdf
  67. Prediction of preeclampsia and small for gestational age by uterine artery pulsatility index at 11-13 weeks View pdf
  68. Prediction of short-term outcome in pregnant women with suspected preeclampsIa using the sFlt-1/PlGF ratio View pdf
  69. Prehypertension as a predictive factor of preeclampsia in adolescents' pregnancy View pdf
  70. Prenatal diagnosis of placenta accreta treated by post-partum hysterectomy View pdf
  71. Prenatal stress modifies RNA expression of HSD11β-2 and the hypothalamic-pituitary-adrenocortical axis in FGR View pdf
  72. Relationship between intercellular adhesion molecule-1 and morbidly adherent placenta View pdf
  73. Role of cerebroplacental ratio in normal growing foetus for the detection of abnormal perinatal outcomes View pdf
  74. Selenium concentration and other markers of oxidative and antioxidative system in intrauterine growth restriction View pdf
  75. Serum lipid, lipocalin-2 levels in preeclamptic and non-preeclamptic pregnants with intrauterine growth retardation View pdf
  76. Serum sFlt-1 levels in Polish women during pregnancies complicated by hypertensive disorders View pdf
  77. Slowing of fetal growth in the third trimester, a predictor of significant placental pathology View pdf
  78. STV analysis and prediction of adverse perinatal outcome and birthweight in singleton term pregnancies View pdf
  79. Survival and neurodevelopmental effects of Docosahexaenoic acid and Lactoferrin in an IUGR animal model View pdf
  80. The fetal umbilical artery Doppler as a tool for universal third trimester screening View pdf
  81. The first trimester screening for preeclampsia: our experience. View pdf
  82. The outcome of pregnancies with unexplained increased HCG levels at first trimester screening View pdf
  83. The relationship between; intrapartum cerebroplacental ratio and adverse perinatal outcomes in term fetuses View pdf
  84. The significance of low and high birth weight in the characteristics of women reproductive health View pdf
  85. The small fetuses: one year of our experience View pdf
  86. The utility of 11-13 weeks scan and maternal biochemistry in differentiating between cystic lesions of placenta View pdf
  87. The value of uterine artery Doppler, sFLT-1, PlGF and PAPP-A in predicting pre-eclampsia in advanced age women View pdf
  88. Third trimester growth velocity in detection of late-onset FGR View pdf
  89. Three-dimensional reconstruction of the cervical segment of the uterine artery at 11 – 14 weeks’ gestation View pdf
  90. Umbilical artery doppler: how high is the maximum velocity and how minimal is the minimum velocity? View pdf
  91. Umbilical artery half peak systolic velocity deceleration time in early-onset fetal growth restriction View pdf
  92. Use of cerebroplacental ratio in ultrasound at Royal Berkshire Hospital View pdf
  93. Uterine artery blood flow volume in patients with high risk of preeclampsia View pdf
  94. Value of doppler ultrasonography in predicting fetal well-being in pregnant women with preecclampsia View pdf
  95. Velamentous and marginal cord insertion: the impacts on pregnancy compications View pdf
29652588291428262807290827322676252729162856270728083075303130382727286430742469300427442838254830783079304524812959270827342892277128702863314329502966296826112910305030432934304729312853250729572952256425592954299125692557307226532773283328122585283529292971305330702649286129723016275928692650249726932865271327382958279924982492294030212871279328932549293527502849263724652828
© 2018 The Fetal Medicine Foundation